Richard Kefford - Dissemin

Dissemin is shutting down on January 1st, 2025

Language
Login

Papers authored by Richard Kefford

This paper is made freely available by the publisher.

2019 Russell J. Diefenbach

ORCID

, Jenny H. Lee, Dario Strbenac

ORCID

, Jean Yh H. Yang, Alexander M. Menzies, Matteo S. Carlino

ORCID

, Georgina V. Long

ORCID

, Andrew J. Spillane, Jonathan R. Stretch, John F. Thompson, Robyn Pm M. Saw, Sydney Ch’ng, Richard A. Scolyer

ORCID

, Richard F. Kefford

ORCID

, Helen Rizos

Analysis of the Whole-Exome Sequencing of Tumor and Circulating Tumor DNA in Metastatic Melanoma

Download from doi.org

This paper is made freely available by the publisher.

Russell J. Diefenbach

ORCID

, Jenny H. Lee, David Chandler, Yinan Wang, Christian Pflueger

ORCID

, Georgina Long

ORCID

, Richard A. Scolyer

ORCID

, Matteo S. Carlino

ORCID

, Alexander M. Menzies, Richard F. Kefford

ORCID

, Helen Rizos

Hypermethylation of Circulating Free DNA in Cutaneous Melanoma

Download from doi.org

This paper is made freely available by the publisher.

Mark J. McCabe, kConFab, Marie-Emilie A. Gauthier, Chia-Ling Chan, Tanya J. Thompson, Sunita M. C. De Sousa, Clare Puttick, John P. Grady, Velimir Gayevskiy, Jiang Tao, Kevin Ying, Arcadi Cipponi, Niantao Deng, Alex Swarbrick, Melissa L. Thomas and 125 other authors

Development and validation of a targeted gene sequencing panel for application to disparate cancers

Download from www.nature.com

This paper is made freely available by the publisher.

Sandra Viz Lasheras, Roser Pujol, Johanna I. Kiiski, Taru A. Muranen, Laurence Venat-Bouvet, Kyriaki Michailidou, C. Soon Lee, Rodney Scott, Goska Leslie, John Forbes, Investigators Abctb, Adrienne Morey, Nirmala Pathmanathan, Deborah Marsh, Nicholas Wilcken and 486 other authors

The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer.

Download from www.nature.com

This paper is made freely available by the publisher.

Christian Menzer, Alexander M. Menzies, Matteo S. Carlino

ORCID

, Irene Reijers, Emma J. Groen, Jan Willem B. de Groot, Thomas Eigentler, Astrid A. M. van der Veldt, Douglas B. Johnson, Max Schlaak

ORCID

, Frank Meiss, Bastian Schilling, Hans M. Westgeest

ORCID

, Ralf Gutzmer, Claudia Pföhler and 15 other authors

Targeted Therapy in Advanced Melanoma With Rare BRAF Mutations

Download from doi.org

This paper was not found in any repository, but could be made available legally by the author.

Zizhen Ming, Su Yin Lim, Richard F. Kefford

ORCID

ORCID

Mitogen‐activated protein kinase dependency in BRAF/RAS wild‐type melanoma: A rationale for combination inhibitors

Upload

This paper is made freely available by the publisher.

Chloe Khoo

ORCID

, Jenny Gilchrist, Jonathan Philip Williamson, Miriam Paul, Richard Kefford

ORCID

Pneumocystis jirovecii in a patient on dose‐dense chemotherapy for early breast cancer

Download from doi.org

This paper was not found in any repository, but could be made available legally by the author.

Georgina V. Long, Robyn P. M. Saw, Serigne Lo, Omgo E. Nieweg, Kerwin F. Shannon, Maria Gonzalez, Alexander Guminski, Jenny H. Lee, Hansol Lee, Peter M. Ferguson

ORCID

, Robert V. Rawson, James S. Wilmott, John F. Thompson, Richard F. Kefford

ORCID

, Sydney Ch'ng and 7 other authors

Neoadjuvant dabrafenib combined with trametinib for resectable, stage IIIB–C, BRAFV600 mutation-positive melanoma (NeoCombi): a single-arm, open-label, single-centre, phase 2 trial

Upload

This paper is made freely available by the publisher.

A. E. Cust

ORCID

, M. Drummond, D. T. Bishop, L. Azizi, H. Schmid, M. A. Jenkins, J. L. Hopper, B. K. Armstrong, J. F. Aitken, R. F. Kefford

ORCID

, G. G. Giles, F. Demenais, A. M. Goldstein, J. H. Barrett, P. A. Kanetsky and 3 other authors

Associations of pigmentary and naevus phenotype with melanoma risk in two populations with comparable ancestry but contrasting levels of ambient sun exposure

Download from onlinelibrary.wiley.com

This paper is made freely available by the publisher.

Georgina V. Long, Reinhard Dummer, Dirk Schadendorf, Mario Santinami, Victoria Atkinson, Mario Mandalà, Vanna Chiarion-Sileni, James Larkin, Marta Nyakas, Caroline Dutriaux, Andrew Haydon, Caroline Robert, Laurent Mortier, Jacob Schachter, Thierry Lesimple and 8 other authors

Reply to E. Hindié and K.R. Hess

Download from doi.org

This paper was not found in any repository, but could be made available legally by the author.

Dirk Schadendorf, Axel Hauschild, Mario Santinami, Victoria Atkinson, Mario Mandalà, Vanna Chiarion-Sileni, James Larkin, Marta Nyakas, Caroline Dutriaux, Andrew Haydon, Caroline Robert, Laurent Mortier, Thierry Lesimple, Ruth Plummer, Jacob Schachter and 8 other authors

Patient-reported outcomes in patients with resected, high-risk melanoma with BRAFV600E or BRAFV600K mutations treated with adjuvant dabrafenib plus trametinib (COMBI-AD): a randomised, placebo-controlled, phase 3 trial

Upload

This paper is made freely available by the publisher.

Jh H. Lee, Rp P. Saw, Jf F. Thompson, S. Lo

ORCID

, Aj J. Spillane, Kf F. Shannon, J. R. Stretch, J. Howle, Am M. Menzies, R. F. Kefford

ORCID

, M. S. Carlino

ORCID

, G. V. Long, R. A. Scolyer, H. Rizos

Pre-operative ctDNA predicts survival in high-risk stage III cutaneous melanoma patients

Download from academic.oup.com

This paper was not found in any repository, but could be made available legally by the author.

O. Hamid, C. Robert, A. Daud, F. S. Hodi, W. J. Hwu, R. Kefford

ORCID

, J. D. Wolchok, P. Hersey, R. Joseph, J. S. Weber

ORCID

, R. Dronca, T. C. Mitchell, A. Patnaik, H. M. Zarour, A. M. Joshua and 5 other authors

Five-year survival outcomes for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001

Upload

This paper is made freely available by the publisher.

Inês Pires da Silva

ORCID

, Inês Pires da Silva, Kevin Yx X. Wang

ORCID

, James S. Wilmott

ORCID

ORCID

, Matteo S. Carlino

ORCID

, John J. Park, Camelia Quek

ORCID

, Matthew Wongchenko

ORCID

, Douglas B. Johnson, Yibing Yan, Jennifer L. McQuade

ORCID

ORCID

, Rajat Rai, Richard F. Kefford

ORCID

and 5 other authors

Distinct Molecular Profiles and Immunotherapy Treatment Outcomes of V600E and V600K BRAF-Mutant Melanoma

Download from aacrjournals.org

This paper is made freely available by the publisher.

2018 Axel Hauschild, Reinhard Dummer, Dirk Schadendorf, Mario Santinami, Victoria Atkinson, Mario Mandalà, Vanna Chiarion-Sileni

ORCID

, James Larkin, Marta Nyakas, Caroline Dutriaux, Andrew Haydon, Caroline Robert, Laurent Mortier, Jacob Schachter, Thierry Lesimple and 8 other authors

Longer Follow-Up Confirms Relapse-Free Survival Benefit With Adjuvant Dabrafenib Plus Trametinib in Patients With Resected BRAF V600–Mutant Stage III Melanoma

Download from doi.org

This paper was not found in any repository, but could be made available legally by the author.

James S. Wilmott

ORCID

, Peter A. Johansson, Felicity Newell, Nicola Waddell, Peter Ferguson

ORCID

ORCID

, Ann-Marie Patch, Katia Nones

ORCID

, Ping Shang, Antonia L. Pritchard, Stephen Kazakoff, Oliver Holmes, Conrad Leonard, Scott Wood, Qinying Xu and 12 other authors

Whole genome sequencing of melanomas in adolescent and young adults reveals distinct mutation landscapes and the potential role of germline variants in disease susceptibility

Upload

This paper is made freely available by the publisher.

Su Y. Lim, Jenny H. Lee

ORCID

, Tuba N. Gide, Alexander M. Menzies, Alexander Guminski, Matteo S. Carlino

ORCID

, Edmond J. Breen, Jean Yh H. Yang

ORCID

, Shila Ghazanfar

ORCID

, Richard F. Kefford

ORCID

, Richard A. Scolyer, Georgina V. Long

ORCID

ORCID

Circulating Cytokines Predict Immune-Related Toxicity in Melanoma Patients Receiving Anti-PD-1–Based Immunotherapy

Download from aacrjournals.org

This paper was not found in any repository, but could be made available legally by the author.

Hildur Helgadottir, Paola Ghiorzo, Remco van Doorn

ORCID

, Susana Puig, Max Levin, Richard Kefford

ORCID

, Martin Lauss, Paola Queirolo, Lorenza Pastorino, Ellen Kapiteijn, Miriam Potrony

ORCID

, Cristina Carrera, Håkan Olsson, Veronica Höiom, Göran Jönsson

Efficacy of novel immunotherapy regimens in patients with metastatic melanoma with germline CDKN2A mutations

Upload

This paper was not found in any repository, but could be made available legally by the author.

R. Dummer, D. Schadendorf, A. Hauschild, M. Santinami, V. G. Atkinson, M. Mandala, V. Chiarion Sileni

ORCID

, J. Larkin, M. S. Nyakas, C. Dutriaux, A. Haydon, L. Mortier, C. Robert, J. Schachter, X. Feng and 5 other authors

Estimate of long-term relapse-free survival (RFS) and analysis of baseline factors associated with RFS in the COMBI-AD trial

Upload

This paper was not found in any repository, but could be made available legally by the author.

V. G. Atkinson, A. Hauschild, M. Santinami, M. Mandala, V. Chiarion Sileni, J. Larkin, M. S. Nyakas, C. Dutriaux, A. Haydon, L. Mortier, C. Robert, J. Schachter, D. Schadendorf, X. Feng, E. de Jong and 5 other authors

Adverse events (AEs) over time in patients (pts) treated with adjuvant dabrafenib plus trametinib (D + T) or placebo (Pbo) in the COMBI-AD trial

Upload

Missing publications? Search for publications with a matching author name.